Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Sandra H. Thomas"'
Autor:
Robert Chen, Paul Frankel, Leslie Popplewell, Tanya Siddiqi, Nora Ruel, Arnold Rotter, Sandra H. Thomas, Michelle Mott, Nitya Nathwani, Myo Htut, Auayporn Nademanee, Stephen J. Forman, Mark Kirschbaum
Publikováno v:
Haematologica, Vol 100, Iss 3 (2015)
This study examines the activity and tolerability of a regimen combining vorinostat and rituximab in patients with indolent B-cell non-Hodgkin lymphoma. A total of 28 patients with newly diagnosed or relapsed/refractory follicular, marginal zone, or
Externí odkaz:
https://doaj.org/article/2ce903f9545448fcba916cb8ad4382fd
Autor:
Ibrahim Aldoss, Samer K. Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R. Wagner, Mary C. Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony Stein, Vinod Pullarkat, Amandeep Salhotra, Monzr M. Al Malki, Ahmed Aribi, Karamjeet Sandhu, Sandra H. Thomas, Lihua E. Budde, Guido Marcucci, Christine E. Brown, Stephen J. Forman
Publikováno v:
Clinical Cancer Research. 29:742-753
Purpose:A phase I/II study evaluating the safety and activity of memory-enriched CD19-directed chimeric antigen receptor (CD19-CAR) T cells in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL).Patients and Methods:In phase I,
Autor:
Stephen J. Forman, Christine E. Brown, Tanya Siddiqi, Leslie Popplewell, Mary C. Clark, Sandra H. Thomas, Lihua E. Budde, Larry W. Kwak, Hong Qin, Saul J. Priceman, Jianying Zhang, Xiwei Wu, Jinhui Wang, Lu Yang, N. Achini Bandara, Aniee Sarkissian, Alfonso Brito, Brenda Aguilar, Wen-Chung Chang, Vibhuti Vyas, Laura Lim, Miriam Walter, Lihong Weng, Ryan Urak, Christian Huynh, Xiuli Wang
Lymphomas with central nervous system (CNS) involvement confer a worse prognosis than those without CNS involvement, and patients currently have limited treatment options. T cells genetically engineered with CD19-targeted chimeric antigen receptors (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3556227d6d0bf66deaa44d3d6fbcc271
https://doi.org/10.1158/2326-6066.c.6550309.v1
https://doi.org/10.1158/2326-6066.c.6550309.v1
Autor:
Stephen J. Forman, Christine E. Brown, Tanya Siddiqi, Leslie Popplewell, Mary C. Clark, Sandra H. Thomas, Lihua E. Budde, Larry W. Kwak, Hong Qin, Saul J. Priceman, Jianying Zhang, Xiwei Wu, Jinhui Wang, Lu Yang, N. Achini Bandara, Aniee Sarkissian, Alfonso Brito, Brenda Aguilar, Wen-Chung Chang, Vibhuti Vyas, Laura Lim, Miriam Walter, Lihong Weng, Ryan Urak, Christian Huynh, Xiuli Wang
Supplementary Figures and Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fcde825de2983e9a50cc6bb7bbbc36
https://doi.org/10.1158/2326-6066.22543540.v1
https://doi.org/10.1158/2326-6066.22543540.v1
Autor:
Susan E. Kane, Stephen J. Forman, Sandra H. Thomas, Xueli Liu, Cecile Donohue, Young Kim, Edward Newman, Jessie Hou, Robert Chen
Brentuximab vedotin (BV) is an antibody–drug conjugate that specifically delivers the potent cytotoxic drug monomethyl auristatin E (MMAE) to CD30-positive cells. BV is FDA approved for treatment of relapsed/refractory Hodgkin lymphoma and anaplast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::460ed47a2b90517acea6940be2e242aa
https://doi.org/10.1158/1535-7163.c.6536229
https://doi.org/10.1158/1535-7163.c.6536229
Autor:
Susan E. Kane, Stephen J. Forman, Sandra H. Thomas, Xueli Liu, Cecile Donohue, Young Kim, Edward Newman, Jessie Hou, Robert Chen
Supplemental Figure 4. Immunohistochemistry for PgP on HL patient biopsy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910205b7c272fadad115dbb2e8f15920
https://doi.org/10.1158/1535-7163.22499697
https://doi.org/10.1158/1535-7163.22499697
Autor:
Susan E. Kane, Stephen J. Forman, Sandra H. Thomas, Xueli Liu, Cecile Donohue, Young Kim, Edward Newman, Jessie Hou, Robert Chen
Supplemental Figure 3. Rhodamine Efflux Assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7bcdaf88cd74c10486a9916d556dff
https://doi.org/10.1158/1535-7163.22499700
https://doi.org/10.1158/1535-7163.22499700
Autor:
Susan E. Kane, Stephen J. Forman, Sandra H. Thomas, Xueli Liu, Cecile Donohue, Young Kim, Edward Newman, Jessie Hou, Robert Chen
Supplemental Figure 1. Karpas-R cultured in the absence of BV regains CD30-positivity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5891e660d21dd4c3982e69a21d2f3e33
https://doi.org/10.1158/1535-7163.22499706.v1
https://doi.org/10.1158/1535-7163.22499706.v1
Autor:
Susan E. Kane, Stephen J. Forman, Sandra H. Thomas, Xueli Liu, Cecile Donohue, Young Kim, Edward Newman, Jessie Hou, Robert Chen
Supplemental Figure 2. Karpas-R cultured in the absence of BV have decreased IC50.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6c240de473fd1b23a899ff21a097a1
https://doi.org/10.1158/1535-7163.22499703
https://doi.org/10.1158/1535-7163.22499703
Autor:
Stephen J. Forman, Christine E. Brown, Guido Marcucci, Lihua E. Budde, Sandra H. Thomas, Karamjeet Sandhu, Ahmed Aribi, Monzr M. Al Malki, Amandeep Salhotra, Vinod Pullarkat, Anthony Stein, Sheng-Hsuan Chien, Vibhuti Vyas, Jinny Paul, Jennifer Simpson, Mary C. Clark, Jamie R. Wagner, Yan Wang, Joycelynne Palmer, Xiuli Wang, Samer K. Khaled, Ibrahim Aldoss
Toxicity management algorithms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e58714af1e2eb6050ccfd02f62a82ea
https://doi.org/10.1158/1078-0432.22490543
https://doi.org/10.1158/1078-0432.22490543